Filing Flows › Indivior Pharmaceuticals (INDV) › Who owns the stock
Who owns Indivior Pharmaceuticals (INDV) stock
312 funds reported Indivior Pharmaceuticals (INDV) shares in their latest 13F filings, worth $4.9B in all. The largest holder is BlackRock ($768M). Last quarter 183 funds added to their stakes and 131 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 18,709,432 | $768M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7,572,287 | $311M | decrease | 2026-06-30 |
| Oaktree Capital Management LP | 6,127,212 | $251M | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 5,495,486 | $225M | decrease | 2026-06-30 |
| State Street | 4,992,071 | $205M | increase | 2026-06-30 |
| Fuller & Thaler Asset Management | 4,615,816 | $189M | increase | 2026-06-30 |
| Morgan Stanley | 3,395,702 | $139M | decrease | 2026-06-30 |
| Franklin Resources | 3,316,358 | $136M | increase | 2026-06-30 |
| Two Seas Capital LP | 3,671,072 | $132M | increase | 2026-09-30 |
| Geode Capital Management, LLC | 3,159,866 | $130M | increase | 2026-06-30 |
| Assenagon Asset Management S.A. | 3,540,344 | $127M | increase | 2026-09-30 |
| Madison Avenue Partners, LP | 2,874,368 | $118M | decrease | 2026-06-30 |
| Mangrove Partners IM, LLC | 2,676,730 | $110M | decrease | 2026-06-30 |
| Citadel Advisors LLC | 2,667,827 | $109M | decrease | 2026-06-30 |
| Driehaus Capital Management LLC | 2,299,054 | $94.3M | increase | 2026-06-30 |
Indivior Pharmaceuticals' latest quarter
Indivior Pharmaceuticals, Q3 2026: revenue $356M (+13% year over year), operating margin 50.6%, net earnings $137M, operating cash flow $97.0M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most INDV stock?
By the latest 13F filings: BlackRock ($768M); Vanguard Portfolio Management LLC ($311M); Oaktree Capital Management LP ($251M); Vanguard Capital Management LLC ($225M); State Street ($205M).
What is the short interest in INDV?
9,414,157 shares were sold short at the 2026-10-15 settlement, -9.6% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.